RhumbLine Advisers’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.76M | Sell |
156,591
-100,559
| -39% | -$3.7M | ﹤0.01% | 1334 |
|
|
2025
Q1 | $9.09M | Buy |
257,150
+5,685
| +2% | +$201K | 0.01% | 1056 |
|
|
2024
Q4 | $11M | Buy |
251,465
+24,473
| +11% | +$1.07M | 0.01% | 1004 |
|
|
2024
Q3 | $10.3M | Sell |
226,992
-1,575
| -0.7% | -$71.4K | 0.01% | 1033 |
|
|
2024
Q2 | $8.87M | Buy |
228,567
+19,257
| +9% | +$747K | 0.01% | 1084 |
|
|
2024
Q1 | $6.75M | Buy |
209,310
+3,952
| +2% | +$127K | 0.01% | 1258 |
|
|
2023
Q4 | $5.89M | Buy |
205,358
+59,786
| +41% | +$1.71M | 0.01% | 1316 |
|
|
2023
Q3 | $4.03M | Buy |
145,572
+6,894
| +5% | +$191K | ﹤0.01% | 1477 |
|
|
2023
Q2 | $3.71M | Buy |
138,678
+5,263
| +4% | +$141K | ﹤0.01% | 1560 |
|
|
2023
Q1 | $2.89M | Buy |
133,415
+14,678
| +12% | +$318K | ﹤0.01% | 1619 |
|
|
2022
Q4 | $2.83M | Buy |
118,737
+10,635
| +10% | +$253K | ﹤0.01% | 1612 |
|
|
2022
Q3 | $2.13M | Buy |
108,102
+17,199
| +19% | +$339K | ﹤0.01% | 1726 |
|
|
2022
Q2 | $1.77M | Buy |
90,903
+14,960
| +20% | +$292K | ﹤0.01% | 1828 |
|
|
2022
Q1 | $1.94M | Sell |
75,943
-4,113
| -5% | -$105K | ﹤0.01% | 1831 |
|
|
2021
Q4 | $2.02M | Sell |
80,056
-754
| -0.9% | -$19K | ﹤0.01% | 1880 |
|
|
2021
Q3 | $2.22M | Buy |
80,810
+2,609
| +3% | +$71.8K | ﹤0.01% | 1852 |
|
|
2021
Q2 | $2.48M | Buy |
78,201
+32,407
| +71% | +$1.03M | ﹤0.01% | 1841 |
|
|
2021
Q1 | $2.1M | Sell |
45,794
-533
| -1% | -$24.5K | ﹤0.01% | 1882 |
|
|
2020
Q4 | $1.83M | Buy |
46,327
+4,799
| +12% | +$190K | ﹤0.01% | 1890 |
|
|
2020
Q3 | $1.45M | Buy |
41,528
+22,719
| +121% | +$791K | ﹤0.01% | 1845 |
|
|
2020
Q2 | $594K | Buy |
18,809
+4,487
| +31% | +$142K | ﹤0.01% | 2268 |
|
|
2020
Q1 | $314K | Buy |
+14,322
| New | +$314K | ﹤0.01% | 2383 |
|